Výsledky vyhledávání - "J. Oshiomogo"

Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199]

Autor: J. Heatherington, Bertus Eksteen, J. Oshiomogo, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan

Publikováno v: Journal of hepatology. 66(1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4a7ec1c626533cfb3f759d9f13b7f7
https://pubmed.ncbi.nlm.nih.gov/27769522

Zobrazit plný text záznamu

RETRACTED: Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease

Autor: B, Eksteen, J, Heatherington, J, Oshiomogo, R, Panaccione, G, Kaplan, S, Ghosh

Publikováno v: Journal of hepatology. 64(2S)

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). The abstract authors and presenters of PS124 - EFFICACY AND SAFETY OF INDUCTION DOSING OF VEDOLIZUMAB FOR REDUCING BI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d342973db4d0e95b911aef9c21a98019
https://pubmed.ncbi.nlm.nih.gov/28042931

Zobrazit plný text záznamu

RETRACTED: PS 124 - Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease

Autor: J. Oshiomogo, J. Heatherington, Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh, Bertus Eksteen

Publikováno v: Journal of Hepatology. 64:S199

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::021acc01411d7a7cebca640b28045759
https://doi.org/10.1016/s0168-8278(16)01707-4

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

RETRACTED: Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease.

Autor: Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S

Publikováno v: Journal of hepatology [J Hepatol] 2016; Vol. 64 (2S), pp. S199. Date of Electronic Publication: 2016 Sep 22.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání